Clinical Trial Update: An Investigational Study Drug, Palbociclib (PD-0332991), Is Being Studied In Patients With Mantle Cell Lymphoma. Patients Must Have Received Prior Treatment(s) For Mantle Cell Lymphoma. [Phase 1]

View source ↗

Summary

Phase 1 trial of palbociclib (PD-0332991) in patients with mantle cell lymphoma has completed, with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma

Drugs mentioned

• Palbociclib (palbociclib)

Snippet

Sponsor: Pfizer | Conditions: Lymphoma, Mantle-Cell | Phase 1 | Status: COMPLETED | Results posted: 2015-06-09